NasdaqGS - Delayed Quote USD

ICU Medical, Inc. (ICUI)

103.99 -2.28 (-2.15%)
At close: May 17 at 4:00 PM EDT
103.99 0.00 (0.00%)
After hours: May 17 at 4:20 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
2,257,132.00
2,259,126.00
2,279,997.00
1,316,308.00
1,271,004.00
Cost of Revenue
1,524,056.00
1,519,253.00
1,582,236.00
824,818.00
809,507.00
Gross Profit
733,076.00
739,873.00
697,761.00
491,490.00
461,497.00
Operating Expense
699,203.00
692,037.00
701,329.00
350,208.00
325,926.00
Operating Income
33,873.00
47,836.00
-3,568.00
141,282.00
135,571.00
Net Non Operating Interest Income Expense
-96,476.00
-95,219.00
-66,375.00
1,982.00
1,924.00
Other Income Expense
-39,075.00
-30,916.00
-44,466.00
-20,078.00
-40,001.00
Pretax Income
-101,678.00
-78,299.00
-114,409.00
123,186.00
97,494.00
Tax Provision
-42,364.00
-48,644.00
-40,123.00
20,051.00
10,624.00
Net Income Common Stockholders
-59,314.00
-29,655.00
-74,286.00
103,135.00
86,870.00
Diluted NI Available to Com Stockholders
-59,314.00
-29,655.00
-74,286.00
103,135.00
86,870.00
Basic EPS
-2.45
-1.23
-3.11
4.86
4.16
Diluted EPS
-2.45
-1.23
-3.11
4.74
4.02
Basic Average Shares
24,143.00
24,091.00
23,868.00
21,206.00
20,907.00
Diluted Average Shares
24,143.00
24,091.00
23,868.00
21,781.00
21,591.00
Total Operating Income as Reported
2,775.00
22,825.00
-42,898.00
123,245.00
98,162.00
Total Expenses
2,223,259.00
2,211,290.00
2,283,565.00
1,175,026.00
1,135,433.00
Net Income from Continuing & Discontinued Operation
-59,314.00
-29,655.00
-74,286.00
103,135.00
86,870.00
Normalized Income
-36,098.20
-5,100.22
-43,352.06
120,465.09
125,016.38
Interest Income
8,402.00
7,508.00
4,430.00
2,840.00
3,677.00
Interest Expense
104,878.00
102,727.00
70,805.00
858.00
1,753.00
Net Interest Income
-96,476.00
-95,219.00
-66,375.00
1,982.00
1,924.00
EBIT
3,200.00
24,428.00
-43,604.00
124,044.00
99,247.00
EBITDA
231,774.00
253,202.00
191,547.00
213,742.00
184,878.00
Reconciled Cost of Revenue
1,524,056.00
1,519,253.00
1,582,236.00
824,818.00
809,507.00
Reconciled Depreciation
228,574.00
228,774.00
235,151.00
89,698.00
85,631.00
Net Income from Continuing Operation Net Minority Interest
-59,314.00
-29,655.00
-74,286.00
103,135.00
86,870.00
Total Unusual Items Excluding Goodwill
-38,693.00
-31,082.00
-47,664.00
-20,705.00
-42,813.00
Total Unusual Items
-38,693.00
-31,082.00
-47,664.00
-20,705.00
-42,813.00
Normalized EBITDA
270,467.00
284,284.00
239,211.00
234,447.00
227,691.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-15,477.20
-6,527.22
-16,730.06
-3,374.92
-4,666.62
12/31/2020 - 3/31/1992

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

MMSI Merit Medical Systems, Inc.
81.89
-0.45%
 
NVST Envista Holdings Corporation
18.53
-3.14%
 
HAE Haemonetics Corporation
95.73
+0.98%
 
TFX Teleflex Incorporated
217.64
-0.43%
 
RGEN Repligen Corporation
171.94
+0.53%
 
WST West Pharmaceutical Services, Inc.
355.64
+0.43%
 
CZMWY Carl Zeiss Meditec AG
103.78
-1.36%
 
ATRI Atrion Corporation
465.25
+2.06%
 
XRAY DENTSPLY SIRONA Inc.
28.28
-0.35%
 
COO The Cooper Companies, Inc.
97.31
-0.60%